Hogan Lovells advises Osiris in US$660 million acquisition by Smith & Nephew

Washington, D.C., 13 March 2019 – International law firm Hogan Lovells has advised Osiris Therapeutics, Inc., (NASDAQ: OSIR), a developer of regenerative medicine products, in an agreement to be acquired by British medical technology group Smith & Nephew plc for $19 a share or approximately US$660 million.

Osiris, a Maryland-based company, has developed a range of products including Grafix® and Stravix® that are used orthopedics, sports medicine and wound care. 

The companies expect to close the transaction in the second quarter of 2019, subject to customary regulatory and closing conditions. More details about the transaction can be found here. 

The Hogan Lovells team was led by partners John Beckman and Les Reese with support from  partner Carin Carithers, senior associates Katherine Keeley and Ben Clark, and associates Lena Al-Marzoog, Jamie Weatherby and Nick Eckstein.

About Hogan Lovells

Hogan Lovells is a leading global legal practice providing business-oriented legal advice and high-quality service across its exceptional breadth of practices to clients around the world.

“Hogan Lovells” or the “firm” is an international legal practice that includes Hogan Lovells US LLP and Hogan Lovells International LLP. For more information, see www.hoganlovells.com.


Back To Listing

Loading data